Cours Evogene Ltd TEL AVIV STOCK EXCHANGE
Actions
IL0011050551
Recherche biotechnologique et médicale
CA 2024 * | 17 M 6,47 Md 15,53 M | CA 2025 * | 31,5 M 11,99 Md 28,77 M | Capitalisation | 33,94 M 12,92 Md 31 M |
---|---|---|---|---|---|
Résultat net 2024 * | -20 M -7,61 Md -18,27 M | Résultat net 2025 * | -17 M -6,47 Md -15,53 M | VE / CA 2024 * | 2 x |
Trésorerie nette 2024 * | - 0 0 | Trésorerie nette 2025 * | - 0 0 | VE / CA 2025 * | 1,08 x |
PER 2024 * |
-
| PER 2025 * |
-
| Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 98,34% |
Dernier transcript sur Evogene Ltd
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Ofer Haviv
CEO | Chief Executive Officer | 58 | 01/01/02 |
Yaron Eldad
DFI | Director of Finance/CFO | 57 | 01/04/22 |
Mark Kapel
CTO | Chief Tech/Sci/R&D Officer | 48 | 01/01/05 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Dan Falk
BRD | Director/Board Member | 79 | 17/11/21 |
Sarit Firon
CHM | Chairman | 58 | 11/08/16 |
Leon Recanati
BRD | Director/Board Member | 76 | 01/05/05 |
Varia. 1 janv. | Capi. | |
---|---|---|
+1,51% | 42,75 Md | |
+8,57% | 41,34 Md | |
+49,22% | 41,61 Md | |
-12,36% | 26,59 Md | |
+8,92% | 25,49 Md | |
-25,13% | 18,12 Md | |
+29,17% | 12,24 Md | |
-3,12% | 11,76 Md | |
+6,35% | 11 Md |